Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.

McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP.

Lancet. 2001 Feb 10;357(9254):436-9.

PMID:
11273064
2.

Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease.

Di Bona D, Candore G, Franceschi C, Licastro F, Colonna-Romano G, Cammà C, Lio D, Caruso C.

Brain Res Rev. 2009 Oct;61(2):60-8. doi: 10.1016/j.brainresrev.2009.05.001. Epub 2009 May 13. Review.

PMID:
19445962
3.

[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].

Panza F, Solfrizzi V, D'Introno A, Capurso C, Colacicco AM, Torres F, Altomare E, Capurso A.

Recenti Prog Med. 2002 Sep;93(9):489-97. Review. Italian.

PMID:
12355988
4.

Genetic susceptibility factors for Alzheimer's disease.

Richard F, Amouyel P.

Eur J Pharmacol. 2001 Jan 19;412(1):1-12. Review.

PMID:
11166730
5.

Genetics of Vascular Dementia: Systematic Review and Meta-Analysis.

Sun JH, Tan L, Wang HF, Tan MS, Tan L, Li JQ, Xu W, Zhu XC, Jiang T, Yu JT.

J Alzheimers Dis. 2015;46(3):611-29. doi: 10.3233/JAD-143102. Review.

PMID:
25835425
6.

Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications.

Cacabelos R, Fernández-Novoa L, Lombardi V, Corzo L, Pichel V, Kubota Y.

Neurol Res. 2003 Sep;25(6):567-80. Review.

PMID:
14503010
7.

Is apolipoprotein E4 an important risk factor for vascular dementia?

Rohn TT.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3504-11. eCollection 2014. Review.

8.

Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.

Cacabelos R, Fernández-Novoa L, Corzo L, Amado L, Pichel V, Lombardi V, Kubota Y.

Neurol Res. 2004 Jul;26(5):459-80. Review.

PMID:
15265264
9.

Susceptibility genetics in the etiopathogenesis of Alzheimer's disease: role for potential confounding factors.

Harrington CR, Roth M.

Int Psychogeriatr. 1997 Sep;9(3):229-44. Review. No abstract available.

PMID:
9513025
10.

Vascular risk and genetics of sporadic late-onset Alzheimer's disease.

Panza F, D'Introno A, Colacicco AM, Basile AM, Capurso C, Kehoe PG, Capurso A, Solfrizzi V.

J Neural Transm (Vienna). 2004 Jan;111(1):69-89. Epub 2003 Dec 3. Review.

PMID:
14714217
11.

Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR.

Mt Sinai J Med. 2010 Jan-Feb;77(1):82-102. doi: 10.1002/msj.20155. Review.

12.
13.

Genetics of dementia.

Russell MB.

Acta Neurol Scand Suppl. 2010;(190):58-61. doi: 10.1111/j.1600-0404.2010.01377.x. Review.

PMID:
20586737
14.

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P; World Federation of Neurology Dementia Research Group.

Lancet Neurol. 2008 Sep;7(9):812-26. doi: 10.1016/S1474-4422(08)70169-8. Epub 2008 Jul 28. Review. Erratum in: Lancet Neurol. 2008 Oct;7(10):867.

15.

Genetics of vascular dementia - review from the ICVD working group.

Ikram MA, Bersano A, Manso-Calderón R, Jia JP, Schmidt H, Middleton L, Nacmias B, Siddiqi S, Adams HH.

BMC Med. 2017 Mar 6;15(1):48. doi: 10.1186/s12916-017-0813-9. Review.

16.

Interventions for heart disease and their effects on Alzheimer's disease.

Wolozin B, Bednar MM.

Neurol Res. 2006 Sep;28(6):630-6. Review.

17.

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd.

Br J Psychiatry. 2013 May;202(5):329-35. doi: 10.1192/bjp.bp.112.118307. Review.

18.

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.

Mayeux R, Schupf N.

Am J Public Health. 1995 Sep;85(9):1280-4. Review.

19.

Dementia. It's getting better all the time.

Skoog I, Marcusson J, Blennow K.

Lancet. 1998 Dec 19-26;352 Suppl 4:SIV4. Review. No abstract available.

PMID:
9872151
20.

Alzheimer's disease and chronic periodontitis: is there an association?

Gaur S, Agnihotri R.

Geriatr Gerontol Int. 2015 Apr;15(4):391-404. doi: 10.1111/ggi.12425. Epub 2014 Dec 16. Review.

PMID:
25511390

Supplemental Content

Support Center